Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Renowned Speakers

Dr.Rosie D Lyles

Dr.Rosie D Lyles

Director of Clinical Affairs at Medline Industries,Inc USA

Dr.Hiroshi Ohrui

Dr.Hiroshi Ohrui

Yokohama University of Pharmacy Japan

Dr.Philip Norrie

Dr.Philip Norrie

Family Physician Australia

Dr.Joseph Mathew

Dr.Joseph Mathew

Postgraduate Institute of Medical Education and Research India

Infectious Diseases meet 2018

About Conference

Conference Series Ltd Conferences invites all the participants from all over the world to attend ‘Infectious Diseases Meet 2018’ which includes prompt Keynote Presentations, Special Sessions, Workshops, Symposiums, Oral talks, Poster Presentations and Exhibitions.

Infectious Diseases are disorders caused by organisms such as bacteria, viruses, fungi or parasites. Infectious diseases may be of water borne, food borne, vector borne, air borne in human beings as well as in plants and animals. Infectious diseases basically emphasize on the pathogenesis of the bacteria and their therapeutic measures, coalesce of branches of Microbiology Especially Clinical and Diagnostic Microbiology which deals with the cure and prevention of the Infectious diseases. It represents an increasingly important cause of human morbidity and mortality throughout the world. Vaccine  development is thus of great importance in terms of global health.

The conference attains significance when we look at the worldwide deaths due to Infectious Diseases.Tetanus (500,000), Measles(1million),HIV/AIDS(1million),HepatitisB (1.1million), Malaria(2.1million), Diarrhea (3.1 million),Tuberculosis (3.1 million), Respiratory Infections (4.4 million).

Who should attend?













Health Care Professionals

Why to attend?

With members from around the world focused on learning about Emerging Innovative Treatment & Therapeutic Techniques in Infectious Diseases, this is your best opportunity to reach the largest assemblage of participants from the Infectious diseases community. This particular conference conduct Presentations, distributes information, conducts meetings with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World’s eminent speakers, the most recent therapeutic and diagnostic techniques, developments, and the Novel technologies and therapeutic measures for infectious diseases prevention and control are hallmarks of this conference.

 Targeted Audience

 Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments

Infectious Diseases Researchers, Scientists, Faculties, Students

Infectious Diseases Associations and Societies

Medical Colleges

Pharmaceutical Companies and Industries

Medical Devices Manufacturing Companies

Drug Manufacturing Companies and Industries

Laboratory Technicians and Diagnostic Companies

Business Entrepreneurs and Industrialists

Training Institutes

Software Developing Companies

Data Management Companies

For Scientific Sessions please go through the link:

 For Abstract Submission please go through the link:

Sessions/ Tracks

Track 01: Infectious Diseases

Infectious diseases kill more people worldwide than any other single cause. The diseases caused by germs and which may infect any part of the body are called infectious diseases. They can be spread by any means where there is a germ. They are caused by pathogenic microorganisms such as bacteria, virus, parasites and fungi. Germs can be spread by direct or indirect contact. Vaccination, maintenance of proper hygiene and medicines help in the prevention of infection.

Track 02: Causes and Symptoms of Infectious Diseases

Infectious diseases can be caused by bacteria, virus, fungi and parasites through direct contact, indirect contact, insect bites and food contamination. Each infectious disease has its own specific signs and symptoms. General signs and symptoms common to many infectious diseases include fever, diarrhea, fatigue and muscle aches.

Track 03: Problems in infectious disease practice

Infection Control in a health care facility is prevention of the spread of microorganisms from one individual to another individual to prevent these infectious diseases problems frequent hand washing, infection outbreak, water and food in hospital must be maintained.

Track 04: Pediatric Infectious Diseases/ Childhood Infectious Diseases

Pediatric infectious diseases/ childhood infectious diseases are the infectious diseases which are caused in children of different age groups. Pediatric infectious diseases specialist’s takes care of the infections occurring in children and the treatment methods vary for children from adults.

Track 5: Viral Infectious Diseases

Viruses are like hijackers. They invade normal living cells and use those cells to multiply and produce other viruses like themselves. This can kill, damage, or change the cells and make sick. Different viruses attack certain cells in your body such as your liver, respiratory system, or blood.

Track 6: Bacterial Infectious Diseases

Bacteria are microscopic single-celled organisms that live almost everywhere. Bacteria live in every climate and location on earth. Some are airborne while others live in water or soil. Bacteria live on and inside plants, animals, and people. The word "bacteria" has a negative connotation, but bacteria perform many vital functions for organisms and in the environment.

Track 7: Fungal Infectious Diseases

Fungal Infectious Diseases are often caused by fungi that are common in the environment. Most fungi are not dangerous, but some types can be harmful to health. Mild fungal skin diseases can look like a rash and are very common. Fungal diseases in the lungs are often similar to other illnesses such as the flu or tuberculosis. Some fungal infections like fungal meningitis and bloodstream infections are less common than skin and lung infections but can be deadly.

Track 8: Blood infectious Diseases    

Germs can cause infection in human blood and diseases are known as blood borne pathogens. The most common and dangerous germs spread through blood within the hospital are viral hepatitis B and hepatitis c virus. These viruses cause infections and liver injury. This virus cause AIDS. Organisms such as bacteria, viruses, prions, and parasites will be transmitted through blood transfusions. 

Track 9: Epidemiological Diseases

The infectious disease epidemiology encompasses domestic and global work on the epidemiology of emerging and re-emerging infections, global infectious disease threats, disease surveillance, disease detection, development of vaccines and other prevention methods, clinical trials, and the role of infectious pathogens in the pathogenesis of chronic non-communicable diseases such as cancer and cardiovascular disease. The broad range to search the novel pathogens using advanced molecular techniques to longitudinal population based studies to define transmission dynamics and spectrum of disease and survival. Approaches are employed in an interdisciplinary fashion to define etiology, pathogenesis, transmission, and prevention/treatment potential.

Track 10: Global Markets On Infectious Diseases

Global market report of infectious diseases is a complete study of current trends in the infectious diseases therapeutic and diagnostic market, industry growth drivers, advanced therapies and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology for infection diagnosis and treatment. Market reports also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Track 11: Tropical Infectious Diseases

Tropical diseases encompass all diseases that occur solely in the tropics. In practice, the term is often taken to refer to infectious diseases that thrive in hot, humid conditions, such as malaria, leishmaniasis, schistosomiasis, onchocerciasis, lymphatic filariasis, Chagas disease, African trypanosomiasis, and dengue.

Track 12: STD And HIV infection

There are a number of infections and cancers that can develop in people who are living with HIV. There are infections that can be life threatening. These are also known as opportunistic infections. The more common life-threatening infections include a lung infection called Pneumocystis pneumonia (PCP), an eye infection caused by cytomegalovirus (CMV), a brain infection called toxoplasmosis, and a generalized infection called Mycobacterium avium complex (MAC). Cancers that are more common include Hodgkin’s lymphoma, lung cancer, skin cancer, anal cancer, cervical and vaginal cancer in women, and testicular and prostate cancer in men. These cancers can often be successfully treated if they occur in people with HIV who maintain healthy immune systems with HIV treatment.

Track 13: Infection, Immunity and Inflammation

An investigation of key characteristics of viruses, bacteria and other micro-organisms causing infections in humans. The mechanisms by which micro-organisms cause disease and evade the immune system are considered. It then explores the principle components of the immune system, describing the molecules and cells that protect against infection and cancer, and their contribution to innate and adaptive immune responses.

Track 14: Pharmacology and Infectious Diseases

Pandemic, epidemic and endemic infectious diseases are united by a common problem to identify potential pharmacological interventions to treat infections. The large numbers of emerging and neglected infectious diseases are badly affecting the poorest members of the global society; new ways are required to develop high productivity discovery systems that can be applied to a large number of pathogens. The basis for developing methods to prioritize a priori potential drug targets analyzes the pharmacological landscape of an infectious disease.

Track 15: Veterinary Infectious Diseases

These sciences are used to control human health through monitoring and control of zoonotic disease, infectious disease transmitted from non-human animals to humans, food safety, and indirectly through human applications from basic medical research food supply is through livestock health monitoring and treatment, and mental health by keeping pet’s healthy and long living. Veterinary scientists often collaborate with epidemiologists.

Track 16: Antimicrobials/ Antibiotics/ Antibacterial

Antimicrobials/ antibiotics/ antibacterial are the drugs used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. Few antibiotics possess antiprotozoal activity. Antibiotics are not effective against viruses such as the common cold or influenza and their inappropriate use allows the emergence of resistant organisms.

Track 17: Vaccines and Vaccination.

Vaccines are the products that can produce immunity from a disease and can be administered through needle injections, by mouth and by aerosol. Vaccination is the injection of a killed or weakened organism that produces immunity in the body against that organism.

Track 18: Health Care - Infectious Diseases

The infections experience in health care settings has become more challenging. Most of the duty workers get exposed commonly to a variety of infectious diseases during the performance of their duties. The primary route of infections transmission is airborne, contact (direct and indirect) which involves the entry of infectious agents from infected individual to a susceptible individual through physical contact and Indirect contact transmission occurs by susceptible individual physical contact with contaminated items. Infection conference 2018 is going to be a platform to discuss microbes that cause illness and its awareness of exposure in the health care settings.


Track 19: Infectious Diseases Prevention, Control and Cure

Infectious diseases prevention and control is helpful to prevent the transmission of infectious diseases. Aseptic technique is normally applied to prevent the infections caused by different means. Sterilization is another process of killing microorganisms by the application of heat. Disinfection is the process of killing harmful microorganisms. Some infectious diseases can be prevented by avoiding direct contact with the contagious person. Infections can also be controlled and prevented by creating public awareness on various infectious diseases and their outbreaks. Infections can be cured by various antimicrobials.

Track 20: Malaria

Malaria is a mosquito borne infectious disease affecting humans and other animals caused by parasitic protozoans (a group of single celled microorganisms) belonging to the plasmodium type. Malaria symptoms typically include fever, fatigue, vomiting and headaches which can be observed in 10-15 after being bitten by mosquito. In severe cases, it can cause yellow skin, seizures, comaor and even death.

Track 21: Laboratory Diagnosis – Infectious Diseases:

Most of the diseases have similar signs and symptoms but the samples of the infected host body fluid disclose the microbe cause the illness. However, the detection of microbes that causes infectious diseases plays key role in medical research.

Track 22: Bone Infection

A bone infection, also called osteomyelitis, can result when bacteria or fungi invade a bone.In children, bone infections most commonly occur in the long bones of the arms and legs. In adults, they usually appear in the hips, spine, and feet.Bone infections can happen suddenly or develop over a long period of time. If they’re not properly treated, bone infections can leave a bone permanently damaged.

Market Analysis

Scope and Importance of Infection Diseases

Every year, lives are lost because of the spread of infections in hospitals. Health care workers can take steps to prevent the spread of infectious diseases. These steps are part of infection control.  Infection prevention and control measures aim to ensure the protection of those who might be vulnerable to acquiring an infection both in the general community and while receiving care due to health problems, in a range of settings. The basic principle of infection prevention and control is hygiene. Healthcare personnel might need to take additional infection control steps if a PUI or patient with confirmed EVD has other conditions or illnesses caused by specific infectious diseases, such as tuberculosis. Healthcare personnel can be exposed to Ebola virus by touching a patient’s body fluids, contaminated medical supplies and equipment, or contaminated environmental surfaces. Splashes to unprotected mucous membranes (for example, the eyes, nose, or mouth) are particularly hazardous. Procedures that can increase environmental contamination with infectious material or create aerosols should be minimized. healthcare personnel (HCP) refers all people, paid and unpaid, working in healthcare settings who have the potential for exposure to patients and/or to infectious materials, including body substances, contaminated medical supplies and equipment, contaminated environmental surfaces, or aerosols generated during certain medical procedures. HCP include, but are not limited to, physicians, nurses, nursing assistants, therapists, technicians, emergency medical service personnel, dental personnel, pharmacists, laboratory personnel, autopsy personnel, students and trainees, contractual personnel, home healthcare personnel, and people not directly involved in patient care (clerical, dietary, housekeeping, laundry, security, maintenance, billing, chaplains, and volunteers) but potentially exposed to infectious agents that can be transmitted to and from HCP and patients.

Why Tokyo (Japan)?

Japan is the second largest Life science market in the world after USA, Occupying about 10% of Market in each of the global drug and Medical devices market. According to Data monitor, the Japanese biotechnology market had total revenue of $ 43.3 Billion in 2013. By 2017, the market is expected to grow to $ 53.8 Billion.

The Japanese pharmaceutical market is the world’s second-largest, with 2013 sales estimated at $115 billion. Japan accounts for a little less than 10 percent of the global Pharma market, compared with 38.4 percent for the U.S. and 20.7 percent for Western Europe

The Japanese market is a promising region for proteomics companies, as a high amount of proteomics research is being conducted in the country.

Best Places to Visit in Japan:

The most visited places would be Tokyo, Kyoto, and Nara. Some other places with some frequent tourist sightseeing include Nikko, Kamakura, Hakone, Osaka, and Hiroshima.

However, the most visited places are not necessarily the best. There are many excellent places that are not on the tourist radar.

The Yaeyama Islands and Okinawa are also very beautiful but get a lot fewer tourists.

Major Infectious Disease Societies around the Globe

European Society of Clinical Microbiology and Infectious Diseases

International Union of Microbiological Societies

Federation of Infection Societies

Canadian Society of Microbiologists

British Infection Association

Federation of European Microbiological Societies

Welsh Microbiology Association

Clinical Virology Network

American Society for Microbiology

Society for General Microbiology

Infectious Diseases Society of America

Members associated with Infectious Diseases

Centre for Infectious Diseases and Policy includes 218 members

Global Public Health is having 106913 members

Members Pediatric Infectious Disease and Immunology has 3291 members

European Society of Clinical Microbiology and Infectious Diseases has 3438 members

Infectious Diseases Society has 707 members

Universities related to Infectious Diseases

  1. University of Cambridge
  2. Kings College of London
  3. London School of Hygiene and Tropical Medicine
  4. Imperial College London
  5. UCL Institute of Epidemiology and Health care
  6. University of Sheffield
  7. Pediatric Infectious Diseases Society
  8. Columbia University
  9. University of Maryland
  10. Swedish Institute for Infectious Disease Control
  11. Uppsala University
  12. University of Gothenburg
  13. University of Otego
  14. Oslo University
  15. University of Pittsburgh
  16. Emory Health Sciences
  17. Queensland University of Technology
  18. University of Liverpool
  19. University of Colorado Denver
  20. Infectious Diseases Society of America
  21. Medical College of Georgia at Georgia Regents University

Market Research on Infectious Diseases

The global market for infectious disease treatments was valued at $90.4 billion in 2009. This market is expected to increase at a compound annual growth rate (CAGR) of 8.8% to reach $138 billion in 2014. The largest market share belongs to antibiotic treatments for bacterial and fungal diseases at 53% of the total infectious disease treatment market.  Fungal disease treatments will experience a slightly higher compound annual growth rate (CAGR) of 6.2%, from $4.6 billion in 2009 to $6.2 billion in 2014. Viral disease treatments will have the fastest compound annual growth rate (CAGR) of 12.1%, increasing from nearly $45 billion in 2009 to $79 billion in 2014.

Funding allotted for Infectious Diseases

The Centers for Disease Control and Prevention’s (CDC) Procurement and Grants Office (PGO) awards over 25,000 acquisition and assistance actions each year and obligates approximately $11 billion in federal funds. PGO aids in achieving CDC’s mission by quickly and effectively allocating funds to where they are needed. In its Pledge to the American People, CDC commits to be a diligent steward of the funds entrusted to the Agency. PGO ensures this pledge remains intact. To learn more about PGO, please review our FY 2014 Annual Report, Acquisition Snapshot, and Assistance Snapshot.

Global Prevalence of Infectious Diseases

The global market for infectious disease diagnostic, vaccine and pharmaceutical products was $59.2 billion in 2011 and $66.4 billion in 2012.  Market growth looks promising; the overall market value for 2017 is projected to be $96.8 billion after increasing at a compound annual growth rate (CAGR) of 7.8%. The demographic transition is associated with an epidemiological transition in the causes and age of death. A predominant feature of this transition is a decrease in the number of deadly infections occurring during childhood. On the contrary, it is projected that, in 2020, three-quarters of all deaths in developing countries could be due to age-associated diseases. These are predominantly non-communicable diseases, such as cardiovascular disease, cancer, and diabetes. What is the role of infection in the death of elderly individuals? Statistics from the WHO suggest that, in Europe and the United States, ∼5% of the population >60 years old will die as a consequence of infection, compared with ∼20% in Africa. However, although this relative difference in the importance of infection as a cause of death in industrialized countries versus developing countries is certainly relevant, the absolute numbers should be regarded with caution. Indeed, although studies using death certificates to identify causes of death usually find a relatively low importance of infection in industrialized countries, autopsy studies suggest a much higher contribution of infections to the overall causes of death (20%–30%). In the developing world, the leading infectious causes of death are respiratory tract infections, diarrheal diseases, tuberculosis, malaria, and AIDS, which together represent >90% of deaths. The remaining 10% are due to tropical diseases and various other infections. In industrialized countries, respiratory tract infections, bloodstream infections, urinary tract infections, and infections of the digestive system represent 90% of infection-related deaths; other diseases such as tuberculosis, hepatitis B and C, diarrheal diseases, and AIDS represent nearly all of the remaining 10%. As already stated by Kalache in 1996, many infectious diseases “no longer kill but neither do they die”. This aphorism is also a reminder that the impact of infectious diseases should not only be measured by mortality rate, but also by morbidity and quality of life, particularly in the aging population. These parameters are much more difficult to assess objectively, but understanding them will be increasingly important in the future.

We are also obliged to various delegate experts, company representatives and other eminent personalities who supported the conference by facilitating active discussion forums. We sincerely thank the Organizing Committee Members for their gracious presence, support and assistance. With the unique feedback from the event, Conference Series would like to announce the commencement of the “Global Experts Meeting on Infectious Diseases” to be held during August 06-07, 2018, at Tokyo, Japan.

Let us meet again @  Infectious Diseases Meet 2018

For more information please visit:


Worldwide deaths due to Infectious Diseases

To Collaborate Scientific Professionals around the World

Conference Date September 03-04,2018

Speaker Opportunity

Supported By

Journal of Emerging Infectious Diseases Journal of Infectious Diseases & Preventive Medicine Journal of Neuroinfectious Diseases

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by

Media partners & Collaborators & Sponsors


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner


Media Partner

Past Affiliations

Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos
Speaker Logos


  • Antimicrobials/ Antibiotics/ Antibacterial
  • Bacterial Infectious Diseases
  • Blood Infectious Diseases
  • C.neoformans Infection Collapsed
  • Causes And Symptoms Of Infectious Diseases
  • Common Infectious Diseases
  • Deadly Infectious Diseases
  • Ecology And Others
  • Epidemiological Diseases
  • Evolutionary Biology
  • Fungal Infectious Diseases
  • Global Markets On Infectious Diseases
  • Hantavirus
  • Health Care - Infectious Diseases
  • Hemorrhagic Fevers And Acute Viral Infections
  • Infection, Immunity And Inflammation
  • Infectious Diseases
  • Infectious Diseases And Policy Implications
  • Infectious Diseases Epidemiology
  • Infectious Diseases Prevention, Control And Cure
  • Inflammatory Infectious Diseases
  • Influenza
  • Laboratory Diagnosis ? Infectious Diseases
  • Malaria
  • Marburg Virus
  • Measles, Mumps, And Rubella
  • Mosquito Borne Infectious Disease
  • Neuro Infectious Diseases
  • NSAIDS Drug Development
  • Opportunistic Infections
  • Pediatric Infectious Diseases/ Childhood Infectious Diseases
  • Pharmacology And Infectious Diseases
  • Polio
  • Pox Disease
  • Problems In Infectious Disease Practice
  • Rabies
  • Rare Infectious Diseases
  • Respiratory Viruses
  • Rotavirus
  • Smallpox
  • STD And HIV Infections
  • Transplant Infectious Diseases
  • Tropical Infectious Diseases
  • Urinary Tract Infections
  • Vaccines And Vaccination
  • Veterinary Infectious Diseases
  • Viral Hepatitis
  • Viral Infectious Diseases
  • Viral Molecular Epidemiology
  • Virology
  • Zoonotic Viral Diseases